An assessment of the relation between vitamin D levels and electroencephalogram (EEG) changes in migraine patients

Creative Commons License

CANPOLAT M., Topcu A., KARDAŞ F., Ipekten F., PER H., GÜMÜŞ H., ...Daha Fazla

Bratislava Medical Journal, cilt.123, sa.2, ss.92-99, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 123 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.4149/bll_2022_014
  • Dergi Adı: Bratislava Medical Journal
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE
  • Sayfa Sayıları: ss.92-99
  • Anahtar Kelimeler: vitamin D, migraine, electroencephalogram, D DEFICIENCY, SEIZURE FREQUENCY, SSRI MEDICATIONS, VEEG MODELS, EPILEPSY, HEADACHE, CHILDREN
  • Kayseri Üniversitesi Adresli: Hayır

Özet

© 2022, Bratislava Medical Journal. All rights reserved.BACKGROUND: The present study evaluated vitamin D therapy in migraine patients with vitamin D defi ciency and EEG abnormality. METHODS: 140 patients were divided into four groups: Group A; normal vitamin D and EEG, Group B; low vitamin D and normal EEG, Group C; normal vitamin D and pathological EEG, and Group D; low vitamin D and pathological EEG. Patients with low vitamin D received vitamin D therapy. RESULTS: Paediatric Migraine Disability Assessment Scale (PedMIDAS) scores and median attack frequencies time-dependent changes in the patients receiving vitamin D therapy in Group B were signifi cant (p <0.05), but not in the untreated patients in the Group A (p >0.05). Interictal EEG was pathological in 41 (29.3 %) patients. The main EEG fi ndings were focal/hemispheric spike/sharp wave activity at 9.3 %, bilateral/generalized spike/sharp wave activity at 8.6 %, focal slowing at 5.8 %, and bilateral slow-wave activity/background rhythm irregularity at 3.6 %. Changes in EEG fi ndings in between the groups C and D were not signifi cant (p >0.05). There was no signifi cant association between vitamin D levels <20 or ≥20 ng/ mL and EEG fi ndings in Group D (p >0.05). CONCLUSION: Vitamin D therapy positively affects attack frequency and PedMIDAS scores in migraine patients with vitamin D defi ciency/insuffi ciency. No association was determined between EEG fi ndings and vitamin D levels or therapy (Tab. 6, Ref. 35). Text in PDF www.elis.sk